1 Study Coverage

• 1.1 Naproxen API Product Introduction
• 1.2 Global Naproxen API Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Naproxen API Sales in US$ Million for the Year 2017-2028

1.2.2 Global Naproxen API Sales in Volume for the Year 2017-2028

1.3 United States Naproxen API Outlook 2017 VS 2022 VS 2028

1.3.1 United States Naproxen API Sales in US$ Million for the Year 2017-2028

1.3.2 United States Naproxen API Sales in Volume for the Year 2017-2028

1.4 Naproxen API Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4.1 The Market Share of United States Naproxen API in Global, 2017 VS 2022 VS 2028

1.4.2 The Growth Rate of Naproxen API Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.5 Naproxen API Market Dynamics

1.5.1 Naproxen API Industry Trends

1.5.2 Naproxen API Market Drivers

1.5.3 Naproxen API Market Challenges

1.5.4 Naproxen API Market Restraints

1.6 Study Objectives

1.7 Years Considered

2 Market by Purity

• 2.1 Naproxen API Market Segment by Purity
• 2.1.1 0.99

2.1.2 0.995

2.1.3 Others

2.2 Global Naproxen API Market Size by Purity

2.2.1 Global Naproxen API Sales in Value, by Purity (2017, 2022 & 2028)

2.2.2 Global Naproxen API Sales in Volume, by Purity (2017, 2022 & 2028)

2.2.3 Global Naproxen API Average Selling Price (ASP) by Purity (2017, 2022 & 2028)

2.3 United States Naproxen API Market Size by Purity

2.3.1 United States Naproxen API Sales in Value, by Purity (2017, 2022 & 2028)

2.3.2 United States Naproxen API Sales in Volume, by Purity (2017, 2022 & 2028)

2.3.3 United States Naproxen API Average Selling Price (ASP) by Purity (2017, 2022 & 2028)

3 Market by Application

• 3.1 Naproxen API Market Segment by Application
• 3.1.1 Tablets

3.1.2 Capsules

3.1.3 Others

3.2 Global Naproxen API Market Size by Application

3.2.1 Global Naproxen API Sales in Value, by Application (2017, 2022 & 2028)

3.2.2 Global Naproxen API Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 Global Naproxen API Average Selling Price (ASP) by Application (2017, 2022 & 2028)

3.3 United States Naproxen API Market Size by Application

3.3.1 United States Naproxen API Sales in Value, by Application (2017, 2022 & 2028)

3.3.2 United States Naproxen API Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 United States Naproxen API Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Naproxen API Competitor Landscape by Company

• 4.1 Global Naproxen API Market Size by Company
• 4.1.1 Top Global Naproxen API Manufacturers Ranked by Revenue (2021)

4.1.2 Global Naproxen API Revenue by Manufacturer (2017-2022)

4.1.3 Global Naproxen API Sales by Manufacturer (2017-2022)

4.1.4 Global Naproxen API Price by Manufacturer (2017-2022)

4.2 Global Naproxen API Concentration Ratio (CR)

4.2.1 Naproxen API Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Naproxen API in 2021

4.2.3 Global Naproxen API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Naproxen API Manufacturing Base Distribution, Product Type

4.3.1 Global Naproxen API Manufacturers, Headquarters and Distribution of Producing Region

4.3.2 Manufacturers Naproxen API Product Type

4.3.3 Date of International Manufacturers Enter into Naproxen API Market

4.4 Manufacturers Mergers & Acquisitions, Expansion Plans

4.5 United States Naproxen API Market Size by Company

4.5.1 Top Naproxen API Players in United States, Ranked by Revenue (2021)

4.5.2 United States Naproxen API Revenue by Players (2020, 2021 & 2022)

4.5.3 United States Naproxen API Sales by Players (2020, 2021 & 2022)

5 Global Naproxen API Market Size by Region

• 5.1 Global Naproxen API Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Naproxen API Market Size in Volume by Region (2017-2028)
• 5.2.1 Global Naproxen API Sales in Volume by Region: 2017-2022

5.2.2 Global Naproxen API Sales in Volume Forecast by Region (2023-2028)

5.3 Global Naproxen API Market Size in Value by Region (2017-2028)

5.3.1 Global Naproxen API Sales in Value by Region: 2017-2022

5.3.2 Global Naproxen API Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Naproxen API Market Size YoY Growth 2017-2028

6.1.2 North America Naproxen API Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Naproxen API Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Naproxen API Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe Naproxen API Market Size YoY Growth 2017-2028

6.3.2 Europe Naproxen API Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Naproxen API Market Size YoY Growth 2017-2028

6.4.2 Latin America Naproxen API Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.4.6 Colombia

6.5 Middle East and Africa

6.5.1 Middle East and Africa Naproxen API Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Naproxen API Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 Xinhua Pharmaceutical
• 7.1.1 Xinhua Pharmaceutical Corporation Information

7.1.2 Xinhua Pharmaceutical Description and Business Overview

7.1.3 Xinhua Pharmaceutical Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.1.4 Xinhua Pharmaceutical Naproxen API Products Offered

7.1.5 Xinhua Pharmaceutical Recent Development

7.2 Changshu Huagang Pharmaceutical

7.2.1 Changshu Huagang Pharmaceutical Corporation Information

7.2.2 Changshu Huagang Pharmaceutical Description and Business Overview

7.2.3 Changshu Huagang Pharmaceutical Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.2.4 Changshu Huagang Pharmaceutical Naproxen API Products Offered

7.2.5 Changshu Huagang Pharmaceutical Recent Development

7.3 Hebei Jiheng Pharmaceutical

7.3.1 Hebei Jiheng Pharmaceutical Corporation Information

7.3.2 Hebei Jiheng Pharmaceutical Description and Business Overview

7.3.3 Hebei Jiheng Pharmaceutical Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.3.4 Hebei Jiheng Pharmaceutical Naproxen API Products Offered

7.3.5 Hebei Jiheng Pharmaceutical Recent Development

7.4 Granules India Limited

7.4.1 Granules India Limited Corporation Information

7.4.2 Granules India Limited Description and Business Overview

7.4.3 Granules India Limited Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.4.4 Granules India Limited Naproxen API Products Offered

7.4.5 Granules India Limited Recent Development

7.5 The Perrigo Company

7.5.1 The Perrigo Company Corporation Information

7.5.2 The Perrigo Company Description and Business Overview

7.5.3 The Perrigo Company Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.5.4 The Perrigo Company Naproxen API Products Offered

7.5.5 The Perrigo Company Recent Development

7.6 Taj Pharmaceuticals Ltd

7.6.1 Taj Pharmaceuticals Ltd Corporation Information

7.6.2 Taj Pharmaceuticals Ltd Description and Business Overview

7.6.3 Taj Pharmaceuticals Ltd Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.6.4 Taj Pharmaceuticals Ltd Naproxen API Products Offered

7.6.5 Taj Pharmaceuticals Ltd Recent Development

7.7 LGM Pharma

7.7.1 LGM Pharma Corporation Information

7.7.2 LGM Pharma Description and Business Overview

7.7.3 LGM Pharma Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.7.4 LGM Pharma Naproxen API Products Offered

7.7.5 LGM Pharma Recent Development

7.8 Iwaki Seiyaku

7.8.1 Iwaki Seiyaku Corporation Information

7.8.2 Iwaki Seiyaku Description and Business Overview

7.8.3 Iwaki Seiyaku Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.8.4 Iwaki Seiyaku Naproxen API Products Offered

7.8.5 Iwaki Seiyaku Recent Development

7.9 Atom Pharma

7.9.1 Atom Pharma Corporation Information

7.9.2 Atom Pharma Description and Business Overview

7.9.3 Atom Pharma Naproxen API Sales, Revenue and Gross Margin (2017-2022)

7.9.4 Atom Pharma Naproxen API Products Offered

7.9.5 Atom Pharma Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Naproxen API Industry Chain Analysis
• 8.2 Naproxen API Key Raw Materials
• 8.2.1 Key Raw Materials

8.2.2 Naproxen API Distributors

8.3 Naproxen API Production Mode & Process

8.4 Naproxen API Sales and Marketing

8.4.1 Naproxen API Sales Channels

8.4.2 Naproxen API Distributors

8.5 Naproxen API Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
• 10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

Market Analysis and Insights: Global and United States Naproxen API Market
This report focuses on global and United States Naproxen API market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Naproxen API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Purity, 0.99 accounting for % of the Naproxen API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Tablets was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Naproxen API market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Naproxen API Scope and Market Size

Naproxen API market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Naproxen API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Naproxen API market size by players, by Purity and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Purity, the Naproxen API market is segmented into

0.99

0.995

Others

Segment by Application, the Naproxen API market is segmented into

Tablets

Capsules

Others

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Naproxen API Market Share Analysis

Naproxen API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Naproxen API business, the date to enter into the Naproxen API market, Naproxen API product introduction, recent developments, etc.

The major vendors covered:

Xinhua Pharmaceutical

Changshu Huagang Pharmaceutical

Hebei Jiheng Pharmaceutical

Granules India Limited

The Perrigo Company

Taj Pharmaceuticals Ltd

LGM Pharma

Iwaki Seiyaku

Atom Pharma